US 9623091
Factor IX polypeptides and methods of use thereof
granted A61KA61K38/38A61K38/4846
Quick answer
US patent 9623091 (Factor IX polypeptides and methods of use thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/38, A61K38/4846, A61K39/395, A61K39/39533